BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 1.150
+0.025 (2.22%)
Aug 14, 2026, 4:17 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 2.21 million as of August 14, 2026. Its market cap has decreased by -15.13% in one year.
Market Cap
2.21M
Enterprise Value
2.93M
Revenue
51.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
ChartMarket Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.02M to 2.21M, an increase of 116.94%. That is a compound annual growth rate of 11.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.92M | -21.32% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.34% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 10.21M |
| Cizzle Biotechnology Holdings | 7.01M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.83M |
| Thalia Therapeutics | 5.62M |
| Oxford BioDynamics | 5.58M |
| Theracryf | 4.19M |
| Nuformix | 3.68M |